Pfizer has sought emergency approval for its '95 percent effective' vaccine produced with BioNTech.Pfizer said on Friday it is asking US regulators to allow emergency use of its Covid-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic - but not until after a long, hard winter. The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95 percent effective at preventing mild to severe Covid-19 disease in a large, ongoing study. The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorisation, so
Hence then, the article about pfizer seeking emergency use of its covid 19 vaccine in us was published today ( ) and is available onThe New Arab ( Kuwait ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Pfizer seeking emergency use of its Covid-19 vaccine in US )